
Vitality · Peptide Profile
A next-generation triple agonist (GLP-1/GIP/Glucagon) for metabolic and weight management.
Retatrutide is a triple agonist peptide that acts on GLP-1, GIP, and glucagon receptors, representing the new generation of metabolic therapy. It supports potent weight management and improved cardiometabolic markers.
Technical Profile
Size
10 mg
Purity
99%+
Backed by Research
Triple GLP-1/GIP/Glucagon agonism
Potent weight management
Improved metabolic markers
10 mg — $85 USD · $120 CAD · ₡40,000 CRC · 20 mg — $120 USD · $160 CAD · ₡55,000 CRC · 30 mg — $160 USD · $190 CAD · ₡70,000 CRC · 40 mg — $190 USD · $220 CAD · ₡90,000 CRC
Research Use Notice
All products are sold solely for legitimate in vitro laboratory research purposes. They are not intended for human consumption, animal use, therapeutic use, cosmetic use, dietary supplementation, or diagnostic purposes. Statements regarding these products have not been evaluated by the FDA.